Lantern Pharma Inc.(LTRN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LTRN Lantern Pharma Inc.

盘后交易 10-12 16:37:51 EDT

0.7370

-0.0757

-9.31%

盘后0.7395

+0.0025+0.34%

16:14 EDT

最高0.8500	最低0.7201	成交量18.15万
今开0.8490	昨收0.8127	日振幅15.98%
总市值1,101万	流通市值907.71万	总股本1,494万
成交额13.89万	换手率1.47%	流通股本1,232万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"LTRN","market":"US","secType":"STK","nameCN":"Lantern Pharma Inc.","latestPrice":0.737,"timestamp":1791835200000,"preClose":0.8127,"halted":0,"volume":181453,"hourTrading":{"tag":"盘后","latestPrice":0.7395,"preClose":0.737,"latestTime":"16:14 EDT","volume":542,"amount":399.4915064,"timestamp":1791836074947,"change":0.0025,"changeRate":0.003392,"amplitude":0.003392},"delay":0,"changeRate":-0.09314630244862802,"floatShares":12316328,"shares":14935600,"eps":-1.636229,"marketStatus":"盘后交易","change":-0.0757,"latestTime":"10-12 16:37:51 EDT","open":0.849,"high":0.85,"low":0.7201,"amount":138878,"amplitude":0.159838,"askPrice":0.8027,"askSize":100,"bidPrice":0.6493,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-1.636229,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1791849600000},"marketStatusCode":4,"adr":0,"listingDate":1591848000000,"exchange":"NASDAQ","adjPreClose":0.8127,"preHourTrading":{"tag":"盘前","latestPrice":0.84,"preClose":0.8127,"latestTime":"09:25 EDT","volume":1182,"amount":964.6492302,"timestamp":1791811500182,"change":0.0273,"changeRate":0.033592,"amplitude":0.085764},"postHourTrading":{"tag":"盘后","latestPrice":0.7395,"preClose":0.737,"latestTime":"16:14 EDT","volume":542,"amount":399.4915064,"timestamp":1791836074947,"change":0.0025,"changeRate":0.003392,"amplitude":0.003392},"volumeRatio":0.641389,"impliedVol":0.2172,"impliedVolPercentile":0.1235},"requestUrl":"/m/hq/s/LTRN","defaultTab":"news","newsList":[{"id":"1166643255","title":"Lantern Pharma（纳斯达克：LTRN）分拆Open-Medicine AI为独立公司，推动多智能体AI协同科学家平台商业化及医学变革","url":"https://stock-news.laohu8.com/highlight/detail?id=1166643255","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1166643255?lang=zh_cn&edition=full","pubTime":"2026-08-03 19:31","pubTimestamp":1785756675,"startTime":"0","endTime":"0","summary":"Lantern Pharma（纳斯达克股票代码：LTRN）宣布，将Open-Medicine AI独立分拆，以加快其多智能体AI协同科学家平台的商业化进程，并拓展其应用边界，旨在彻底改造医学领域。这一战略举措，旨在将该前沿技术平台推向更广阔的市场，释放其潜在价值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LTRN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191917245","title":"Lantern Pharma推进EMA批准的LP-184（Zirdafulven）针对生物标志物筛选的晚期膀胱癌1B/2期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1191917245","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191917245?lang=zh_cn&edition=full","pubTime":"2026-07-28 19:46","pubTimestamp":1785239171,"startTime":"0","endTime":"0","summary":"Lantern Pharma Inc.即将推进一项已获欧洲药品管理局（EMA）批准的1B/2期临床试验。这项试验的核心药物是LP-184（即Zirdafulven）。目标人群是经过生物标志物筛选的晚期膀胱癌患者。此举标志着该公司在精准肿瘤学领域迈出了关键一步。试验旨在评估该药物在这一特定患者群体中的疗效与安全性。通过生物标志物的筛选，治疗有望实现更高的精准度。这或将为那些传统疗法效果有限的晚期膀胱癌患者带来新的希望。Lantern Pharma正致力于将LP-184推向临床前沿，以验证其创新潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LTRN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159516492","title":"Lantern Pharma旗下LP-300为L858R非小细胞肺癌患者带来8.9个月中位无进展生存期；部分应答持续超两年","url":"https://stock-news.laohu8.com/highlight/detail?id=1159516492","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1159516492?lang=zh_cn&edition=full","pubTime":"2026-06-02 20:15","pubTimestamp":1780402548,"startTime":"0","endTime":"0","summary":"Lantern Pharma公司宣布，其候选药物LP-300在一项针对携带L858R突变的非小细胞肺癌患者的研究中，取得了显著的中期数据结果。数据显示，接受LP-300治疗的患者群体，其中位无进展生存期达到了8.9个月。更令人鼓舞的是，部分患者表现出了持久的治疗应答，其持续时间已超过两年，这为这一难治性肺癌亚型的患者带来了新的希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LTRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192417150","title":"Lantern Pharma宣布针对Lp-300在非吸烟NSCLC患者中的Harmonic™二期试验FDA C类会议请求取得圆满成果","url":"https://stock-news.laohu8.com/highlight/detail?id=1192417150","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1192417150?lang=zh_cn&edition=full","pubTime":"2026-05-19 19:33","pubTimestamp":1779190389,"startTime":"0","endTime":"0","summary":"Lantern Pharma公司宣布，其针对旗下药物Lp-300在非吸烟非小细胞肺癌（NSCLC）患者中进行的Harmonic™二期临床试验，向美国食品药品监督管理局（FDA）提交的C类会议请求已获得成功结果。这一积极进展标志着该试验方案与监管路径获得了关键性的初步认可，为后续临床开发奠定了重要基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LTRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136842954","title":"Lantern Pharma Inc. 宣布Harmoni试验将终止对照组，转为单臂设计","url":"https://stock-news.laohu8.com/highlight/detail?id=1136842954","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136842954?lang=zh_cn&edition=full","pubTime":"2026-05-19 19:32","pubTimestamp":1779190366,"startTime":"0","endTime":"0","summary":"Lantern Pharma Inc. 宣布，其正在进行的Harmoni试验将终止对照组，并转为单臂设计。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LTRN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151979103","title":"Lantern Pharma Inc. 宣布与现有股东及一家机构投资者进行最高925万美元的注册直接发行","url":"https://stock-news.laohu8.com/highlight/detail?id=1151979103","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1151979103?lang=zh_cn&edition=full","pubTime":"2026-05-13 20:01","pubTimestamp":1778673717,"startTime":"0","endTime":"0","summary":"Lantern Pharma Inc. 宣布，公司已与现有股东及一家机构投资者达成协议，将进行一项最高价值达925万美元的注册直接发行。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LTRN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191406065","title":"Lantern Pharma Inc. 旗下LP-300展现8.3个月中位无进展生存期 且无额外毒性","url":"https://stock-news.laohu8.com/highlight/detail?id=1191406065","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191406065?lang=zh_cn&edition=full","pubTime":"2026-04-20 20:09","pubTimestamp":1776686962,"startTime":"0","endTime":"0","summary":"Lantern Pharma Inc. 近日宣布，其研发的药物LP-300在临床试验中取得积极成果。数据显示，接受LP-300治疗的患者群体，其中位无进展生存期达到8.3个月。尤为关键的是，该治疗方案并未引入额外的毒性反应，显示出良好的安全性特征。这一结果标志着LP-300在特定患者群体中的治疗潜力，为后续的临床开发提供了有力支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LTRN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518789671","title":"Lantern Pharma Inc.盘中异动 下午盘股价大跌5.46%报3.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518789671","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518789671?lang=zh_cn&edition=full","pubTime":"2025-03-11 03:09","pubTimestamp":1741633784,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日03时09分，Lantern Pharma Inc.股票出现波动，股价急速下跌5.46%。Lantern Pharma Inc.股票所在的生物技术行业中，整体涨幅为0.25%。其相关个股中，Mineralys Therapeutics, Inc.、Checkpoint Therapeutics, Inc.、Aeon Biopharma, Inc.涨幅较大，Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为6241.48%、3860.05%、1021.55%，振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Biodexa Pharmaceuticals Plc，振幅分别为90.44%、88.14%、59.34%。Lantern Pharma Inc.公司简介：Lantern Pharma Inc是一家人工智能公司，致力于改变肿瘤药物发现和开发的成本、速度和时间表。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311030944abf37882&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311030944abf37882&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LTRN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516776966","title":"Lantern Pharma Inc.盘中异动 股价大跌5.39%报3.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516776966","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516776966?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:41","pubTimestamp":1741099305,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时41分，Lantern Pharma Inc.股票出现波动，股价急速下挫5.39%。Lantern Pharma Inc.股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Protagenic Therapeutics, Inc.、Capricor Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1118.41%、1103.36%、453.16%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Hepion Pharmaceuticals, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为37.67%、22.25%、21.85%。Lantern Pharma Inc.公司简介：Lantern Pharma Inc是一家人工智能公司，致力于改变肿瘤药物发现和开发的成本、速度和时间表。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304224145963947cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304224145963947cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LTRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516666881","title":"Lantern Pharma Inc.盘中异动 下午盘急速下跌6.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516666881","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516666881?lang=zh_cn&edition=full","pubTime":"2025-03-04 03:47","pubTimestamp":1741031249,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日03时47分，Lantern Pharma Inc.股票出现波动，股价大幅下挫6.08%。Lantern Pharma Inc.股票所在的生物技术行业中，整体涨幅为0.70%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Biocardia, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4562.65%、208.37%、182.02%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Lantern Pharma Inc.公司简介：Lantern Pharma Inc是一家人工智能公司，致力于改变肿瘤药物发现和开发的成本、速度和时间表。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304034729989a555e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304034729989a555e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LTRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514685907","title":"Lantern Pharma Inc.盘中异动 股价大涨5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514685907","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514685907?lang=zh_cn&edition=full","pubTime":"2025-02-26 23:04","pubTimestamp":1740582244,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日23时04分，Lantern Pharma Inc.股票出现异动，股价快速上涨5.52%。Lantern Pharma Inc.股票所在的生物技术行业中，整体跌幅为0.14%。其相关个股中，Enveric Biosciences, Inc.、Renovaro Inc.、Humacyte Inc C/Wts 27/08/2026 涨幅较大，Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为4662.53%、160.40%、143.18%，振幅较大的相关个股有Enveric Biosciences, Inc.、Humacyte Inc C/Wts 27/08/2026 、Renovaro Inc.，振幅分别为155.93%、39.47%、29.31%。Lantern Pharma Inc.公司简介：Lantern Pharma Inc是一家人工智能公司，致力于改变肿瘤药物发现和开发的成本、速度和时间表。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262304059893b13e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262304059893b13e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LTRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514157090","title":"Lantern Pharma Inc.盘中异动 早盘急速上涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514157090","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514157090?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:36","pubTimestamp":1740494163,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时36分，Lantern Pharma Inc.股票出现波动，股价急速拉升5.11%。Lantern Pharma Inc.股票所在的生物技术行业中，整体涨幅为0.25%。其相关个股中，Moleculin Biotech, Inc.、Silexion Therapeutics Corp、Gt Biopharma, Inc.涨幅较大，Gt Biopharma, Inc.、Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为776.65%、491.17%、261.99%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Gt Biopharma, Inc.、Moleculin Biotech, Inc.，振幅分别为20.51%、20.20%、15.89%。Lantern Pharma Inc.公司简介：Lantern Pharma Inc是一家人工智能公司，致力于改变肿瘤药物发现和开发的成本、速度和时间表。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022522360398924dc3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022522360398924dc3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LTRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513773363","title":"Lantern Pharma Inc.盘中异动 早盘股价大跌5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513773363","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513773363?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:31","pubTimestamp":1740411079,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时31分，Lantern Pharma Inc.股票出现波动，股价急速下跌5.54%。Lantern Pharma Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Pepgen Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为205.11%、86.17%、27.91%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为137.23%、55.69%、53.34%。Lantern Pharma Inc.公司简介：Lantern Pharma Inc是一家人工智能公司，致力于改变肿瘤药物发现和开发的成本、速度和时间表。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224233120962ea711&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224233120962ea711&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LTRN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513297538","title":"Lantern Pharma Inc.盘中异动 股价大涨6.00%报4.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513297538","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513297538?lang=zh_cn&edition=full","pubTime":"2025-02-22 00:25","pubTimestamp":1740155114,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日00时25分，Lantern Pharma Inc.股票出现波动，股价急速拉升6.00%。Lantern Pharma Inc.股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Nkgen Biotech, Inc.、Osr Holdings Inc C/Wts 09/02/2028 、Osr Holdings, Inc.涨幅较大，Nkgen Biotech, Inc.、Aditxt, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为197.26%、140.86%、119.51%，振幅较大的相关个股有Osr Holdings, Inc.、Osr Holdings Inc C/Wts 09/02/2028 、Nkgen Biotech, Inc.，振幅分别为70.14%、57.50%、48.19%。Lantern Pharma Inc.公司简介：Lantern Pharma Inc是一家人工智能公司，致力于改变肿瘤药物发现和开发的成本、速度和时间表。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222002515a24ec97c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222002515a24ec97c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LTRN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512614301","title":"Lantern Pharma Inc.盘中异动 早盘快速下跌6.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512614301","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512614301?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:39","pubTimestamp":1739893167,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日23时39分，Lantern Pharma Inc.股票出现波动，股价急速跳水6.19%。Lantern Pharma Inc.股票所在的生物技术行业中，整体涨幅为0.79%。其相关个股中，Estrella Immunopharma Inc C/Wts 29/09/2028、Allogene Therapeutics, Inc.、Abvc Biopharma, Inc.涨幅较大，Aditxt, Inc.、Moleculin Biotech, Inc.、Solid Biosciences Inc.较为活跃，换手率分别为367.91%、163.01%、139.04%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.，振幅分别为148.75%、92.00%、79.17%。Lantern Pharma Inc.公司简介：Lantern Pharma Inc是一家人工智能公司，致力于改变肿瘤药物发现和开发的成本、速度和时间表。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218233927a24abc65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218233927a24abc65&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LTRN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510635885","title":"Lantern Pharma Inc.盘中异动 股价大跌6.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510635885","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510635885?lang=zh_cn&edition=full","pubTime":"2025-02-12 01:51","pubTimestamp":1739296282,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日01时51分，Lantern Pharma Inc.股票出现波动，股价急速下挫6.93%。Lantern Pharma Inc.股票所在的生物技术行业中，整体跌幅为1.79%。其相关个股中，Omega Therapeutics, Inc.、Dominari Holdings Inc.、Lipella Pharmaceuticals Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为3062.88%、1386.22%、464.47%，振幅较大的相关个股有Omega Therapeutics, Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.，振幅分别为143.33%、59.66%、58.60%。Lantern Pharma Inc.公司简介：Lantern Pharma Inc是一家人工智能公司，致力于改变肿瘤药物发现和开发的成本、速度和时间表。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212015123a24225a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212015123a24225a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LTRN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510861667","title":"Lantern Pharma Inc.盘中异动 早盘股价大跌6.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510861667","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510861667?lang=zh_cn&edition=full","pubTime":"2025-02-10 23:27","pubTimestamp":1739201238,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日23时27分，Lantern Pharma Inc.股票出现异动，股价急速下跌6.31%。Lantern Pharma Inc.股票所在的生物技术行业中，整体跌幅为0.18%。其相关个股中，Biodexa Pharmaceuticals Plc、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为2535.35%、1503.42%、950.90%，振幅较大的相关个股有Ocean Biomedical, Inc.、Biodexa Pharmaceuticals Plc、Immatics N V C/Wts 01/07/2025 ，振幅分别为69.83%、66.09%、50.50%。Lantern Pharma Inc.公司简介：Lantern Pharma Inc是一家人工智能公司，致力于改变肿瘤药物发现和开发的成本、速度和时间表。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502102327189880840f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502102327189880840f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LTRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509747318","title":"Lantern Pharma Inc.盘中异动 股价大涨5.28%报5.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509747318","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509747318?lang=zh_cn&edition=full","pubTime":"2025-02-07 22:32","pubTimestamp":1738938738,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日22时32分，Lantern Pharma Inc.股票出现波动，股价快速拉升5.28%。Lantern Pharma Inc.股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，Conduit Pharmaceuticals Inc.、Engene Holdings Inc C/Wts 31/10/2028  Cl A、Nutriband Inc.涨幅较大，Conduit Pharmaceuticals Inc.、Lipella Pharmaceuticals Inc.、Aditxt, Inc.较为活跃，换手率分别为1067.05%、40.41%、33.81%，振幅较大的相关个股有Conduit Pharmaceuticals Inc.、Nutriband Inc.、Renovorx, Inc.，振幅分别为30.97%、16.49%、10.27%。Lantern Pharma Inc.公司简介：Lantern Pharma Inc是一家人工智能公司，致力于改变肿瘤药物发现和开发的成本、速度和时间表。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207223218961b3915&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207223218961b3915&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LTRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509238076","title":"Lantern Pharma Inc.盘中异动 早盘大幅上涨6.20%报5.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509238076","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509238076?lang=zh_cn&edition=full","pubTime":"2025-02-05 23:27","pubTimestamp":1738769248,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日23时27分，Lantern Pharma Inc.股票出现异动，股价大幅上涨6.20%。Lantern Pharma Inc.股票所在的生物技术行业中，整体涨幅为1.28%。其相关个股中，Oragenics Inc.、Transcode Therapeutics, Inc.、Pasithea Therapeutics Corp.涨幅较大，Pasithea Therapeutics Corp.、Oragenics Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为3966.85%、1166.47%、675.62%，振幅较大的相关个股有Transcode Therapeutics, Inc.、Oragenics Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028，振幅分别为86.20%、59.80%、54.05%。Lantern Pharma Inc.公司简介：Lantern Pharma Inc是一家人工智能公司，致力于改变肿瘤药物发现和开发的成本、速度和时间表。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205232728987b8631&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205232728987b8631&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LTRN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509692084","title":"Lantern Pharma Inc.盘中异动 快速上涨5.52%报4.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509692084","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509692084?lang=zh_cn&edition=full","pubTime":"2025-02-05 00:36","pubTimestamp":1738686971,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日00时36分，Lantern Pharma Inc.股票出现异动，股价大幅拉升5.52%。Lantern Pharma Inc.股票所在的生物技术行业中，整体涨幅为1.61%。其相关个股中，Estrella Immunopharma Inc C/Wts 29/09/2028、Azitra Inc、Evaxion Biotech As涨幅较大，Azitra Inc、Evaxion Biotech As、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为1665.95%、932.46%、537.84%，振幅较大的相关个股有Azitra Inc、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Quoin Pharmaceuticals Ltd，振幅分别为72.82%、49.88%、47.29%。Lantern Pharma Inc.公司简介：Lantern Pharma Inc是一家人工智能公司，致力于改变肿瘤药物发现和开发的成本、速度和时间表。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205003611abc24009&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205003611abc24009&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LTRN"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lanternpharma.com","stockEarnings":[{"period":"1week","weight":-0.0551},{"period":"1month","weight":-0.5408},{"period":"3month","weight":-0.7742},{"period":"6month","weight":-0.5875},{"period":"1year","weight":-0.8241},{"period":"ytd","weight":-0.7318}],"compareEarnings":[{"period":"1week","weight":0.0116},{"period":"1month","weight":0.0212},{"period":"3month","weight":0.0313},{"period":"6month","weight":0.1459},{"period":"1year","weight":0.16},{"period":"ytd","weight":0.1417}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Lantern Pharma Inc.成立于2013年11月7日。该公司是一家临床阶段生物技术公司，致力于利用人工智能（“A.I.”），机器学习和基因组数据来简化药物开发流程并使将要治疗的患者能从其靶向肿瘤治疗中受益。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.031352},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.024402},{"month":3,"riseRate":0.5,"avgChangeRate":0.045479},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.042374},{"month":5,"riseRate":0.666667,"avgChangeRate":0.14166},{"month":6,"riseRate":0.5,"avgChangeRate":0.000218},{"month":7,"riseRate":0.142857,"avgChangeRate":-0.070288},{"month":8,"riseRate":0.428571,"avgChangeRate":0.012635},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.133082},{"month":10,"riseRate":0,"avgChangeRate":-0.157635},{"month":11,"riseRate":0.666667,"avgChangeRate":0.098056},{"month":12,"riseRate":0.5,"avgChangeRate":0.047826}],"exchange":"NASDAQ","name":"Lantern Pharma Inc.","nameEN":"Lantern Pharma Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Lantern Pharma Inc.(LTRN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Lantern Pharma Inc.(LTRN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Lantern Pharma Inc.,LTRN,Lantern Pharma Inc.股票,Lantern Pharma Inc.股票老虎,Lantern Pharma Inc.股票老虎国际,Lantern Pharma Inc.行情,Lantern Pharma Inc.股票行情,Lantern Pharma Inc.股价,Lantern Pharma Inc.股市,Lantern Pharma Inc.股票价格,Lantern Pharma Inc.股票交易,Lantern Pharma Inc.股票购买,Lantern Pharma Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Lantern Pharma Inc.(LTRN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Lantern Pharma Inc.(LTRN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}